American International Group’s Akcea Therapeutics Inc AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,840
| Closed | -$179K | – | 3181 |
|
|
2020
Q3 | $179K | Sell |
9,840
-222
| -2% | -$3.15K | ﹤0.01% | 2203 |
|
|
2020
Q2 | $138K | Buy |
10,062
+2,609
| +35% | +$40.3K | ﹤0.01% | 2334 |
|
|
2020
Q1 | $107K | Sell |
7,453
-429
| -5% | -$7.04K | ﹤0.01% | 2269 |
|
|
2019
Q4 | $134K | Buy |
7,882
+29
| +0.4% | +$540 | ﹤0.01% | 2456 |
|
|
2019
Q3 | $121K | Sell |
7,853
-55
| -0.7% | -$1.17K | ﹤0.01% | 2490 |
|
|
2019
Q2 | $185K | Sell |
7,908
-572
| -7% | -$14.1K | ﹤0.01% | 2279 |
|
|
2019
Q1 | $240K | Buy |
8,480
+84
| +1% | +$2.45K | ﹤0.01% | 2117 |
|
|
2018
Q4 | $253K | Sell |
8,396
-64
| -0.8% | -$1.79K | ﹤0.01% | 2063 |
|
|
2018
Q3 | $296K | Buy |
8,460
+153
| +2% | +$4.63K | ﹤0.01% | 2181 |
|
|
2018
Q2 | $197K | Sell |
8,307
-1,281
| -13% | -$30.6K | ﹤0.01% | 2356 |
|
|
2018
Q1 | $246K | Sell |
9,588
-514
| -5% | -$11.1K | ﹤0.01% | 2155 |
|
|
2017
Q4 | $175K | Buy |
10,102
+172
| +2% | +$3.37K | ﹤0.01% | 2398 |
|
|
2017
Q3 | $275K | Buy |
+9,930
| New | +$184K | ﹤0.01% | 2103 |
|
American International Group's AKCA Position: Q4 2020 in Review
American International Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 9,840 shares — an estimated $179K sold.
American International Group first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $296K in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.
- American International Group reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
- American International Group sold 9,840 Akcea Therapeutics Inc shares in Q4 2020, an estimated $179K.
- American International Group first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
- American International Group's Akcea Therapeutics Inc position peaked at $296K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.
Based on American International Group's 13F filing for Q4 2020, filed 12 Feb 2021.